Company Filing History:
Years Active: 2010
Title: Manfrid Eltze: Innovator in iNOS Inhibition
Introduction
Manfrid Eltze is a notable inventor based in Constance, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that serve as inhibitors for specific biological pathways.
Latest Patents
Eltze holds a patent for "Imidazopyridine derivatives useful as iNOS inhibitors." This patent describes compounds of formula (I), where R1, R11, and A have specific meanings as outlined in the patent description. These compounds are recognized for their effectiveness in inhibiting inducible nitric oxide synthase (iNOS), which plays a crucial role in various physiological and pathological processes.
Career Highlights
Manfrid Eltze is currently associated with Nycomed GmbH, a company known for its focus on innovative pharmaceutical solutions. His work at Nycomed has allowed him to explore and develop new therapeutic agents that can address unmet medical needs.
Collaborations
Throughout his career, Eltze has collaborated with esteemed colleagues such as Thomas Fuchss and Andreas Strub. These collaborations have fostered a productive environment for research and innovation, leading to advancements in their respective fields.
Conclusion
Manfrid Eltze's contributions to the field of medicinal chemistry, particularly through his patent on iNOS inhibitors, highlight his role as an influential inventor. His work continues to impact the development of new therapeutic strategies.